Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-21-003597

Chief Commercial Officer sold 20,000 shares at an average $1.08 ($21,685)

From the SEC's structured data for this filing

Trades in this filing

Maloberti Renaud Bertrand · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-12 Sale : show line 1 in the form −6,304 $1.05 $6,619 15,276 D
2021-01-13 Sale : show line 2 in the form −13,696 $1.10 $15,066 1,580 D
Open-market sales · 20,000 sh · avg $1.08 · $21,685
Loading xslF345X03/doc4.xml…